| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1056/NEJM199411243312107 |
| P698 | PubMed publication ID | 7969282 |
| P50 | author | Noel K. Maclaren | Q124236631 |
| P2093 | author name string | Atkinson MA | |
| P2860 | cites work | Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers | Q71401820 |
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1428-1436 | |
| P577 | publication date | 1994-11-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | The pathogenesis of insulin-dependent diabetes mellitus | |
| P478 | volume | 331 |
| Q36007054 | A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin |
| Q34197513 | A functional polymorphism in the promoter/enhancer region of the FOXP3/Scurfin gene associated with type 1 diabetes |
| Q34627998 | A latent autoimmune diabetes in adults patient manifesting severe musculoskeletal complications |
| Q36365755 | A major histocompatibility complex class II restriction for BioBreeding/Worcester diabetes-inducing T cells |
| Q35068487 | A new look at viruses in type 1 diabetes. |
| Q53357215 | A new solid-phase radioimmunoassay to detect anti-GAD65 autoantibodies. |
| Q33385000 | A novel expression platform for the production of diabetes-associated autoantigen human glutamic acid decarboxylase (hGAD65). |
| Q73081435 | A novel high-throughput method for accurate, rapid, and economical measurement of multiple type 1 diabetes autoantibodies |
| Q77817481 | A specific loss of C-series gangliosides in pancreas of streptozotocin-induced diabetic rats |
| Q46497941 | ACE-inhibition ameliorates vascular reactivity and delays diabetes outcome in NOD mice. |
| Q54130985 | Abnormal glucose metabolism in cystic fibrosis. |
| Q83841321 | Acceleration of diabetes development in CXC chemokine receptor 3 (CXCR3)-deficient NOD mice |
| Q37697285 | Acute-Onset Type 1 Diabetes that Developed During the Administration of Olanzapine |
| Q89421329 | Administration of cytokine-induced myeloid-derived suppressor cells ameliorates renal fibrosis in diabetic mice |
| Q43102875 | Advances in childhood onset diabetes |
| Q91946209 | Altered peripheral nerve structure and function in latent autoimmune diabetes in adults |
| Q36853549 | An islet-cell protein tyrosine phosphatase is a likely precursor to the 37-kDa autoantigen in type 1 diabetes: human and macaque sequences, tissue distribution, unique and shared epitopes, and predictive autoantibodies |
| Q50080679 | Analysis of pancreas tissue in a child positive for islet cell antibodies. |
| Q33630358 | Anti hyperglycemic activities of Annona muricata (Linn). |
| Q24652207 | Anti-CD38 autoantibodies in type? diabetes |
| Q37375709 | Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein |
| Q42848810 | Antidiabetic Effect of Essential Oil from Artemisia sieberi Growing in Jordan in Normal and Alloxan Induced Diabetic Rats |
| Q33594140 | Antigen-based immunotherapy for autoimmune disease: from animal models to humans? |
| Q35057559 | Antihyperglycemic effect of the alcoholic seed extract of Swietenia macrophylla on streptozotocin-diabetic rats |
| Q51083567 | Antihyperglycemic effects of Platycodon grandiflorum (Jacq.) A. DC. extract on streptozotocin-induced diabetic mice. |
| Q33616086 | Approaches in type 1 diabetes research: A status report |
| Q40899250 | Aspects of the etiology, prediction, and prevention of insulin-dependent diabetes mellitus in childhood |
| Q80109583 | Association of interferon-gamma and interleukin 10 genotypes and serum levels with partial clinical remission in type 1 diabetes |
| Q40557066 | Atopic eczema in early childhood could be protective against Type 1 diabetes |
| Q53647613 | Autoantibodies and high-risk HLA susceptibility markers in first-degree relatives of Brazilian patients with type 1 diabetes mellitus: a progression to disease based study. |
| Q38262910 | Autoimmune diabetes recurrence should be routinely monitored after pancreas transplantation |
| Q43980273 | Autoimmune diabetes: caught in the causality trap? |
| Q41641771 | Autoimmune diabetic neuropathy |
| Q37301852 | Autoimmune type 1 diabetes genetic susceptibility encoded by human leukocyte antigen DRB1 and DQB1 genes in Tunisia |
| Q37599503 | Autoimmune/Inflammatory Syndrome Induced by Adjuvants and Thyroid Autoimmunity |
| Q44790299 | Bioluminescent monitoring of islet graft survival after transplantation |
| Q37000150 | Biomarkers for type 1 diabetes. |
| Q34678384 | Birth weight and childhood onset type 1 diabetes: population based cohort study |
| Q41361351 | CD28/B7 regulation of autoimmune diabetes |
| Q74630532 | CD86 gene polymorphisms: no association with Type I diabetes among Finnish subjects |
| Q37692502 | CRISPR-targeted genome editing of mesenchymal stem cell-derived therapies for type 1 diabetes: a path to clinical success? |
| Q80033309 | Can we justify living donor islet transplantation? |
| Q63348382 | Cell-mediated immune response to β casein in recent-onset insulin-dependent diabetes: implications for disease pathogenesis |
| Q34460740 | Challenges to vaccine safety |
| Q51931908 | Change in perceived health and functioning over time in patients with type I diabetes mellitus. |
| Q37689425 | Checkpoints in the progression of autoimmune disease: lessons from diabetes models |
| Q33372575 | Childhood hemolytic uremic syndrome is associated with adolescent-onset diabetes mellitus |
| Q36945752 | Circadian rhythm connections to oxidative stress: implications for human health |
| Q40830121 | Clinical islet cell transplantation. Are we there yet? |
| Q28280437 | Cloning of a novel member of the low-density lipoprotein receptor family |
| Q44687001 | Combined gastrin and epidermal growth factor treatment induces islet regeneration and restores normoglycaemia in C57Bl6/J mice treated with alloxan |
| Q73264754 | Comparative analysis of epitope recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different autoimmune disorders |
| Q71914703 | Comparative immunocytochemical study of MHC class II expression in human donor pancreas and isolated islets |
| Q34355278 | Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes |
| Q33867520 | Cortex cinnamomi extract prevents streptozotocin- and cytokine-induced beta-cell damage by inhibiting NF-kappaB |
| Q40497673 | Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection |
| Q73832189 | Critical roles of CD30/CD30L interactions in murine autoimmune diabetes |
| Q34660346 | Curcumin ameliorates autoimmune diabetes. Evidence in accelerated murine models of type 1 diabetes |
| Q37789411 | Current approaches to measuring human islet-antigen specific T cell function in type 1 diabetes |
| Q34579971 | Current understanding of feline diabetes: part 1, pathogenesis |
| Q34715503 | Cytokine and immunosuppressive therapies of type 1 diabetes mellitus |
| Q41604760 | DNA vaccines for the treatment of autoimmune disease |
| Q37497704 | Development and feasibility testing of an intervention to support active lifestyles in youths with type 1 diabetes-the ActivPals programme: a study protocol |
| Q73501292 | Diabetes Results from a Late Change in the Autoimmune Response of NOD Mice |
| Q46958824 | Diabetes in children and adolescents. Areas of controversy |
| Q77534180 | Diabetes mellitus |
| Q34451762 | Diabetes mellitus and coronary heart disease |
| Q34761949 | Diabetes mellitus during interferon therapy for chronic viral hepatitis |
| Q72293553 | Diabetes' sweet little mystery |
| Q77977867 | Diet can influence the ability of nicotinamide to prevent diabetes in the non-obese diabetic mouse: a preliminary study |
| Q42648552 | Do non-insulin-dependent diabetes mellitus (NIDDM) and insulin-dependent diabetes mellitus (IDDM) share genetic susceptibility loci? An analysis of putative IDDM susceptibility regions in familial NIDDM. |
| Q38021404 | Does familial clustering of risk factors for long-term diabetic complications leave any place for genes that act independently? |
| Q75229396 | Duration of breast feeding and bovine serum albumin antibody levels in type 1 diabetes: a case-control study |
| Q38994655 | Dynamics of diabetes and obesity: Epidemiological perspective |
| Q42911235 | Early induction of GAD(65)-reactive Th2 response in type 1 diabetic children treated with alum-formulated GAD(65). |
| Q41012417 | Early infant diets and insulin-dependent diabetes |
| Q37131987 | Effect of active fraction isolated from the leaf extract of Dregea volubilis [Linn.] Benth. on plasma glucose concentration and lipid profile in streptozotocin-induced diabetic rats |
| Q41438393 | Effect of diabetes mellitus upon male reproductive function |
| Q37494973 | Effect of photopheresis on lymphocyte population in children with newly diagnosed type 1 diabetes |
| Q36406404 | Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia. |
| Q51019283 | Effects of type 2 diabetes mellitus on the pharmacokinetics of berberine in rats. |
| Q73679321 | Efficacy of different Helicobacter pylori eradication regimens in patients affected by insulin-dependent diabetes mellitus |
| Q45883118 | Efficient gene delivery to human and rodent islets with double-stranded (ds) AAV-based vectors |
| Q48446714 | Electrospray ionization tandem mass spectrometric analysis of sulfatide. Determination of fragmentation patterns and characterization of molecular species expressed in brain and in pancreatic islets |
| Q35725874 | Emerging therapies: controlling glucose homeostasis, immunotherapy, islet transplantation, gene therapy, and islet cell neogenesis and regeneration |
| Q34202054 | Endocrine self and gut non-self intersect in the pancreatic lymph nodes |
| Q51104874 | Engineering and expression of the intracellular domain of insulinoma-associated tyrosine phosphatase (IA-2ic), a type 1 diabetes autoantigen, in plants. |
| Q44276960 | Enterovirus infection may induce humoral immune response reacting with islet cell autoantigens in humans |
| Q40853507 | Enterovirus infections and insulin dependent diabetes mellitus--evidence for causality. |
| Q64378313 | Enterovirus infections are associated with the induction of beta-cell autoimmunity in a prospective birth cohort study |
| Q37512178 | Enzyme linked immuno-spot; a useful tool in the search for elusive immune markers in common pediatric immunological diseases |
| Q39446880 | EphA2 targeting peptide tethered bioreducible poly(cystamine bisacrylamide-diamino hexane) for the delivery of therapeutic pCMV-RAE-1γ to pancreatic islets |
| Q48391296 | Epilepsia partialis continua in type 1 diabetes: evolution into epileptic encephalopathy with continuous spike-waves during slow sleep |
| Q88219257 | Establishment of human pluripotent stem cell-derived pancreatic β-like cells in the mouse pancreas |
| Q39906661 | Estimation of genetic risk for Type 1 diabetes mellitus in newborns on dried blood spot |
| Q39319598 | Evaluating the intrinsic cysteine redox-dependent states of the A-chain of human insulin using NMR spectroscopy, quantum chemical calculations, and mass spectrometry |
| Q91045457 | Exhaled volatile substances in children suffering from type 1 diabetes mellitus: results from a cross-sectional study |
| Q59060541 | Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope |
| Q64111171 | Expansion of Murine MSC Impairs Transcription Factor-Induced Differentiation into Pancreatic -Cells |
| Q42059990 | Expression, characterization, processing and immunogenicity of an insulin-dependent diabetes mellitus autoantigen, IA-2, in Sf-9 cells |
| Q34326185 | Factors influencing Islet of Langerhans graft function and monitoring |
| Q35790027 | FokI polymorphism, vitamin D receptor, and interleukin-1 receptor haplotypes are associated with type 1 diabetes in the Dalmatian population |
| Q34072307 | Functional alterations of proinflammatory monocytes by T regulatory cells: implications for the prevention and reversal of type 1 diabetes |
| Q84078434 | Functional consequences of HLA-DQ8 homozygosity versus heterozygosity for islet autoimmunity in type 1 diabetes |
| Q74471851 | Genetic association between interleukin-10 gene promoter region polymorphisms and type 1 diabetes age-at-onset |
| Q29614551 | Global and societal implications of the diabetes epidemic |
| Q84081029 | Glutamic acid decarboxylase epitope protects against autoimmune diabetes through activation of Th2 immune response and induction of possible regulatory mechanism |
| Q34648219 | Group B coxsackievirus diabetogenic phenotype correlates with replication efficiency |
| Q42804452 | Growth arrest- and DNA-damage-inducible 45beta gene inhibits c-Jun N-terminal kinase and extracellular signal-regulated kinase and decreases IL-1beta-induced apoptosis in insulin-producing INS-1E cells |
| Q48015744 | HERV-K10s and immune-mediated (type 1) diabetes |
| Q37238501 | HLA class II DRB1 and DQB1 allelic polymorphism and sclerosing lymphocytic lobulitis of the breast |
| Q36689916 | HLA class II SNP interactions and the association with type 1 diabetes mellitus in Bengali speaking patients of Eastern India. |
| Q40869063 | HLA-DRB1 alleles contribute to determining the prognosis of Japanese diabetes mellitus positive for antibodies to glutamate decarboxylase |
| Q78161086 | HLA-DRB1*0403 is associated with dominant protection against IDDM in the general Dutch population and subjects with high-risk DQA1*0301-DQB1*0302/DQA1*0501-DQB1*0201 genotype |
| Q50946212 | Haploinsufficiency of interferon regulatory factor 4 strongly protects against autoimmune diabetes in NOD mice. |
| Q35544053 | Hepatic Insulin Gene Therapy in Insulin-Dependent Diabetes Mellitus |
| Q43588795 | Hepatic insulin expression improves glycemic control in type 1 diabetic rats |
| Q36416615 | Heterophile antibodies segregate in families and are associated with protection from type 1 diabetes |
| Q45201533 | Homing of human autoreactive T cells into pancreatic tissue of NOD-scid mice |
| Q40442898 | Human leukocyte antigen class I B and C loci contribute to Type 1 Diabetes (T1D) susceptibility and age at T1D onset |
| Q37518209 | IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus |
| Q44468596 | IL-1beta, IFN-gamma and TNF-alpha increase vulnerability of pancreatic beta cells to autoimmune destruction |
| Q35153018 | IL-21 production by CD4+ effector T cells and frequency of circulating follicular helper T cells are increased in type 1 diabetes patients |
| Q28270870 | Identification of a novel type 1 diabetes susceptibility gene, T-bet |
| Q39784479 | Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients |
| Q34441422 | Idiopathic Type 1 diabetes |
| Q47146381 | Immune Checkpoint Inhibitor-Associated Type 1 Diabetes Mellitus: Case Series, Review of the Literature, and Optimal Management |
| Q33654261 | Immune markers for monitoring the progression of autoimmune disease |
| Q38016902 | Immunologic and metabolic biomarkers of β-cell destruction in the diagnosis of type 1 diabetes |
| Q40101442 | Immunotherapeutic effects of pentoxifylline in type 1 diabetic mice and its role in the response of T-helper lymphocytes |
| Q35017238 | Impact of vitamin D receptor gene polymorphisms in pathogenesis of Type-1 diabetes mellitus |
| Q36368009 | In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha. |
| Q33589474 | In vivo imaging of insulitis in autoimmune diabetes |
| Q60192352 | In vivo multimodal imaging of transplanted pancreatic islets |
| Q51033548 | Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. |
| Q33499699 | Increasing incidence of pediatric type 1 diabetes mellitus in Southeastern Wisconsin: relationship with body weight at diagnosis |
| Q81744581 | Increasing incidence of type 1 diabetes in population from Santiago of Chile: trends in a period of 18 years (1986-2003) |
| Q28348712 | Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis C |
| Q35122841 | Induction of indoleamine 2, 3-dioxygenase in human dendritic cells by a cholera toxin B subunit-proinsulin vaccine. |
| Q37682917 | Induction of oral tolerance to prevent diabetes with transgenic plants requires glutamic acid decarboxylase (GAD) and IL-4. |
| Q45754792 | Induction of virus-induced IDDM in virus resistant mice without lymphocyte maturation |
| Q90079848 | Influence of Vitamin D on Islet Autoimmunity and Beta-Cell Function in Type 1 Diabetes |
| Q35004275 | Inhibition of Ca2+-independent phospholipase A2β (iPLA2β) ameliorates islet infiltration and incidence of diabetes in NOD mice |
| Q28249932 | Insulin in human milk and the prevention of type 1 diabetes |
| Q34707037 | Insulin renders diabetic rats resistant to acute ischemic stroke by arresting nitric oxide reaction with superoxide to form peroxynitrite |
| Q74454186 | Insulin-Dependent Diabetes Mellitus: Islet Changes in Relation to Etiology and Pathogenesis |
| Q41743574 | Insulin-dependent diabetes mellitus during alpha-interferon therapy for chronic viral hepatitis |
| Q41373877 | Insulin-dependent diabetes mellitus: the hypothesis of molecular mimicry between islet cell antigens and microorganisms |
| Q40881602 | Insulins |
| Q74023402 | Intercellular adhesion molecule-1 (ICAM-1) K469E polymorphism: no association with type 1 diabetes among Finns |
| Q34410660 | Interleukin 10 suppresses experimental chronic, granulomatous inflammation induced by bacterial cell wall polymers |
| Q81326683 | Interleukin 18 promoter polymorphisms are not strongly associated with type I diabetes in a UK population |
| Q28362310 | Intradermal skin test with diabetes specific antigens in patients with type 1 diabetes |
| Q37017270 | Investigation The Role of Gender on The HLA-DRB1 and -DQB1 Association with Type 1 Diabetes Mellitus in Iranian Patients |
| Q73012266 | Is type II diabetes another extrahepatic manifestation of HCV infection? |
| Q73833098 | Islet abnormalities associated with an early influx of dendritic cells and macrophages in NOD and NODscid mice |
| Q40972733 | Islet cell neogenesis in the pancreas |
| Q39065609 | Islet inflammation in type 2 diabetes and physiology |
| Q34479316 | Islet-specific CTL cloned from a type 1 diabetes patient cause beta-cell destruction after engraftment into HLA-A2 transgenic NOD/scid/IL2RG null mice |
| Q79294755 | Juxtaglomerular apparatus T-cell infiltration affects glomerular structure in Type 1 diabetic patients |
| Q89737280 | Knowledge, Attitude, and Practice of Diabetes Mellitus Among the Saudi Population in Riyadh, Saudi Arabia: A Quantitative Study |
| Q36060484 | Large-Scale Discovery and Validation Studies Demonstrate Significant Reductions in Circulating Levels of IL8, IL-1Ra, MCP-1, and MIP-1β in Patients With Type 1 Diabetes |
| Q35156175 | Lespedeza davurica (Lax.) Schindl. extract protects against cytokine-induced β-cell damage and streptozotocin-induced diabetes |
| Q34103574 | Long-lasting immune responses 4 years after GAD-alum treatment in children with type 1 diabetes |
| Q46132304 | Long-term monitoring of transplanted islets using positron emission tomography |
| Q90185620 | Loss of interleukin-10 exacerbates early Type-1 diabetes-induced bone loss |
| Q37527795 | MRI as a tool to monitor islet transplantation |
| Q57188448 | MRI of insulitis in autoimmune diabetes |
| Q36526326 | Major histocompatibility complex class I-restricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use a prevalent T cell receptor alpha chain gene rearrangement |
| Q85039092 | Maternal dietary n‐6/n‐3 fatty acid ratio affects type 1 diabetes development in the offspring of non‐obese diabetic mice |
| Q84006142 | Maternal intake of vitamin D during pregnancy and risk of advanced beta cell autoimmunity and type 1 diabetes in offspring |
| Q43110580 | Measurement of IgG levels can serve as a biomarker in newly diagnosed diabetic children |
| Q41628489 | Mechanisms underlying the loss of self tolerance in NOD mice |
| Q34444323 | Medical care from childhood to adulthood in type 1 and type 2 diabetes |
| Q35614319 | Medical myths involving diabetes |
| Q42462724 | Metabolic and immune parameters at clinical onset of insulin-dependent diabetes: a population-based study. IMDIAB Study Group. Immunotherapy Diabetes. |
| Q38983706 | Metabolic syndrome in sub-Saharan Africa: "smaller twin" of a region's prostatic diseases? |
| Q38240129 | Modulation of diabetes-mellitus-induced male reproductive dysfunctions in experimental animal models with medicinal plants |
| Q37947597 | Molecular imaging: a promising tool to monitor islet transplantation |
| Q73734443 | Molecular mimicry in type 1 diabetes mellitus revisited: T-cell clones to GAD65 peptides with sequence homology to Coxsackie or proinsulin peptides do not crossreact with homologous counterpart |
| Q35166486 | Myeloid-derived suppressor cells prevent type 1 diabetes in murine models |
| Q39774757 | Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401. |
| Q37374258 | Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism. |
| Q36147791 | NeuroD1 gene and interleukin-18 gene polymorphisms in type 1 diabetes in Dalmatian population of Southern Croatia |
| Q52566324 | Neutrophilic granulocytes are the predominant cell type infiltrating pancreatic islets in contact with ABO-compatible blood. |
| Q36065469 | New therapies for type 1 diabetes mellitus |
| Q40934999 | Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). |
| Q40477828 | Nicotinamide and Diabetes Prevention |
| Q37096895 | Non-invasive detection of transplanted pancreatic islets |
| Q39660840 | Non-viral systemic delivery of Fas siRNA suppresses cyclophosphamide-induced diabetes in NOD mice |
| Q34983969 | Noninvasive imaging of islet grafts using positron-emission tomography |
| Q89719095 | Novel Mouse miRNA Chr13_novelMiR7354-5p Improves Bone-Marrow-Derived Mesenchymal Stem Cell Differentiation into Insulin-Producing Cells |
| Q37088197 | Novel biomarkers in type 1 diabetes |
| Q36853493 | Novel detection of pancreatic and duodenal homeobox 1 autoantibodies (PAA) in human sera using luciferase immunoprecipitation systems (LIPS) assay |
| Q33672280 | Novel therapeutic effects of sesamin on diabetes-induced cardiac dysfunction |
| Q49189362 | On type 1 diabetes mellitus pathogenesis |
| Q29393228 | Opinion: Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetes |
| Q64268733 | Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models? |
| Q91778233 | Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes |
| Q41112023 | Pancreas transplantation: a managed cure approach to diabetes |
| Q34028055 | Pancreatic and islet transplantation |
| Q52893248 | Paracrine GABA and insulin regulate pancreatic alpha cell proliferation in a mouse model of type 1 diabetes. |
| Q73674800 | Peptide-specific cytotoxicity of T lymphocytes against glutamic acid decarboxylase and insulin in type 1 diabetes mellitus |
| Q51095612 | Peripheral neuropathies in diabetes. |
| Q42000560 | Physical fitness in children with type 1 diabetes measured with six-minute walk test |
| Q36269185 | Polymeric delivery of therapeutic RAE-1 plasmid to the pancreatic islets for the prevention of type 1 diabetes |
| Q43596212 | Polymorphism in gene for islet autoantigen, IA-2, and type 1 diabetes in Japanese subjects |
| Q56905165 | Possible association between CTLA4 DNA polymorphisms and early onset type 1 diabetes in a UK population |
| Q38071770 | Potential role of mesenchymal stromal cells in pancreatic islet transplantation |
| Q35093549 | Prediabetes in children: natural history, diagnosis, and preventive strategies |
| Q35101668 | Protection against autoimmune diabetes by silkworm-produced GFP-tagged CTB-insulin fusion protein. |
| Q37308802 | Protection of nonobese diabetic mice from autoimmune diabetes by reduction of islet mass before insulitis |
| Q33592891 | Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23) |
| Q47347761 | Quality of life of patients with type I diabetes mellitus |
| Q36645596 | Radioiodinated naphthylalanine derivatives targeting pancreatic beta cells in normal and nonobese diabetic mice |
| Q46543844 | Regulatory T cell-associated activity in photopheresis-induced immune tolerance in recent onset type 1 diabetes children |
| Q44679781 | Relationship between glycemic control, ethnicity and socioeconomic status in Hispanic and white non-Hispanic youths with type 1 diabetes mellitus |
| Q37178859 | Relationships of DTI findings with neurocognitive dysfunction in children with Type 1 diabetes mellitus |
| Q41432895 | Reprogramming human gallbladder cells into insulin-producing β-like cells |
| Q26998424 | Role of nutritional factors at the early life stages in the pathogenesis and clinical course of type 1 diabetes |
| Q26782979 | Roles of Commensal Microbiota in Pancreas Homeostasis and Pancreatic Pathologies |
| Q34079225 | Sample size requirements for studies of treatment effects on beta-cell function in newly diagnosed type 1 diabetes |
| Q34991070 | Schizophrenia and diabetes |
| Q40473381 | Self and non-self antigen in diabetic autoimmunity: Molecules and mechanisms |
| Q38755624 | Sensitivity profile of the human EndoC-βH1 beta cell line to proinflammatory cytokines |
| Q39265474 | Sensory nerve regeneration after epithelium wounding in normal and diabetic cornea. |
| Q77841517 | Serum IFN-gamma and IL-10 levels are associated with disease progression in non-obese diabetic mice |
| Q24623113 | Shared and distinct genetic variants in type 1 diabetes and celiac disease |
| Q78554047 | Similar incidence of type 1 diabetes in two ethnically different populations (Italy and Slovenia) is sustained by similar HLA susceptible/protective haplotype frequencies |
| Q45873999 | Simultaneous stimulation of Fas-mediated apoptosis and blockade of costimulation prevent autoimmune diabetes in mice induced by multiple low-dose streptozotocin |
| Q37015391 | Specific HLA-DRB and -DQB alleles and haplotypes confer disease susceptibility or resistance in Bahraini type 1 diabetes patients |
| Q36181700 | Spontaneous complete remission of type 1 diabetes mellitus in an adult - review and case report |
| Q84452304 | Study of interleukin-10 promoter region polymorphisms (-1082A/G, -819T/C and -592A/C) in type 1 diabetes mellitus in Turkish population |
| Q34629092 | Suppression of dendritic cell activation by diabetes autoantigens linked to the cholera toxin B subunit. |
| Q42035404 | Suppression of diabetes in non-obese diabetic (NOD) mice by oral administration of a cholera toxin B subunit-insulin B chain fusion protein vaccine produced in silkworm |
| Q40621226 | Suppressor mechanism of serum thymic factor on tumor necrosis factor-α-induced apoptosis in the mouse pancreatic β-cell line |
| Q52165714 | Survey of mRNAs encoding zinc transporters and other metal complexing proteins in pancreatic islets of rats from birth to adulthood: similar patterns in the Sprague-Dawley and Wistar BB strains. |
| Q73489749 | T cells and autoantibodies to human HSP70 in type 1 diabetes in children |
| Q41911811 | T helper 2 (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice |
| Q38917507 | TNFA-TNFB haplotypes modify susceptibility to type I diabetes mellitus independently of HLA class II in a Moroccan population |
| Q35579471 | TRAIL and DcR1 expressions are differentially regulated in the pancreatic islets of STZ- versus CY-applied NOD mice |
| Q41603351 | Tactics for type I diabetes |
| Q89477264 | Targeting Glycoproteins as a therapeutic strategy for diabetes mellitus and its complications |
| Q28214902 | The HLA class I A locus affects susceptibility to type 1 diabetes |
| Q52945572 | The IL12B 3' untranslated region DNA polymorphism is not associated with early-onset type 1 diabetes. |
| Q91738006 | The Role Of Adiponectin, TNF-α And Glutathione In The Pathogenesis And Evolution Of Type 1 Diabetes |
| Q39233053 | The Role of Dendritic Cell Maturation in the Induction of Insulin-Dependent Diabetes Mellitus |
| Q56902043 | The association of CTLA-4 and HLA class II autoimmune risk genotype with regulatory T cell marker expression in 5-year-old children |
| Q28215658 | The association of specific HLA class I and II alleles with type 1 diabetes among Filipinos |
| Q44796616 | The changing presentation of children with newly diagnosed type 1 diabetes mellitus. |
| Q40953976 | The clinical significance of an autoimmune response against glutamic acid decarboxylase |
| Q42001469 | The destructive action of IL-1alpha and IL-1beta in IDDM is a multistage process: evidence and confirmation by apoptotic studies, induction of intermediates and electron microscopy. |
| Q33752748 | The diagnosis and classification of diabetes mellitus in nonpregnant adults |
| Q43289250 | The effects of resveratrol on cyclooxygenase-1 and cyclooxygenase-2 mRNA and protein levels in diabetic rat kidneys |
| Q94562813 | The emerging roles of WBP2 oncogene in human cancers |
| Q36586011 | The identification of CD4+ T cell epitopes with dedicated synthetic peptide libraries |
| Q50740395 | The incidence of type 1 diabetes mellitus in Greek-Cypriot children and adolescents in 1990-2000. |
| Q36265212 | The influence of tobacco smoking on humoral immune response in insulin dependent diabetic pregnancy |
| Q52196097 | The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. |
| Q87135143 | The new insights from DPP-4 inhibitors: their potential immune modulatory function in autoimmune diabetes |
| Q71420898 | The role of CD8+ T cells in the initiation of insulin-dependent diabetes mellitus |
| Q24675746 | The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS |
| Q37984231 | Toll-like receptors, the NLRP3 inflammasome, and interleukin-1β in the development and progression of type 1 diabetes |
| Q36823176 | Toward a model of memory enhancement in schizophrenia: glucose administration and hippocampal function |
| Q34359584 | Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence. |
| Q53928842 | Transfer of dendritic cells (DC) ex vivo stimulated with interferon-gamma (IFN-gamma) down-modulates autoimmune diabetes in non-obese diabetic (NOD) mice. |
| Q35837580 | Type 1 Diabetes Prevention in NOD Mice by Targeting DPPIV/CD26 Is Associated with Changes in CD8⁺T Effector Memory Subset |
| Q38130263 | Type 1 diabetes and celiac disease: The effects of gluten free diet on metabolic control |
| Q35216879 | Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy |
| Q33657633 | Type 1 diabetes, cardiovascular complications and sesame ( zhī má). |
| Q39425320 | Type 1 diabetes-associated HLA-DQ8 transdimer accommodates a unique peptide repertoire |
| Q34321603 | Type 1 diabetes: new perspectives on disease pathogenesis and treatment |
| Q33606814 | Type I (insulin-dependent) diabetes is a Th1- and Th2-mediated autoimmune disease |
| Q40439867 | Type I diabetes mellitus and pregnancy |
| Q39413871 | Up-regulation of small intestinal interleukin-17 immunity in untreated coeliac disease but not in potential coeliac disease or in type 1 diabetes |
| Q37634057 | Urinary biomarkers for the early diagnosis of retinopathy and nephropathy in type 1 diabetes mellitus: a "steady stream" of information using proteomics |
| Q42361533 | Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon? |
| Q33975703 | Vaccination strategies for mucosal immune responses |
| Q38184961 | Vascular imaging in diabetes |
| Q41641704 | Vasculitis and the nervous system. Historical perspective and overview |
| Q33852513 | Virus-induced immune dysregulation as a triggering factor for the development of drug rashes and autoimmune diseases: with emphasis on EB virus, human herpesvirus 6 and hepatitis C virus |
| Q36065477 | Viruses and diabetes: is there something sweet about hepatitis C infection? |
| Q38773655 | Vitamin D and diabetes mellitus: Causal or casual association? |
| Q24800803 | Vitamin D receptor initiation codon polymorphism influences genetic susceptibility to type 1 diabetes mellitus in the Japanese population |
| Q44249584 | Vitamin D receptor polymorphism and susceptibility to type 1 diabetes in the Dalmatian population. |
| Q81470421 | [Molecular diagnosis of diabetes mellitus] |
| Q40728434 | beta-cell antigen-specific CD56(+) NKT cells from type 1 diabetic patients: autoaggressive effector T cells damage human CD56(+) beta cells by HLA-restricted and non-HLA-restricted pathways |
| Q96431014 | microRNA-181c-5p promotes the formation of insulin-producing cells from human induced pluripotent stem cells by targeting smad7 and TGIF2 |
Search more.